ISIDORe Integrated Services for Infectious Disease Outbreak Research
- Coordinator
- European Research Infrastructure on Highly Pathogenic Agents, Belgium
- Runs
- 1 February 2022 to 31 July 2025
- Status
- Running
- EU funding
- €21.0m
- Total cost
- €21.0m
- Partners
- 159 organisations in 32 countries
- Type
- Research and Innovation Action
- Grant agreement
- 101046133
What the project is doing
In the project's own words, from its summary on CORDIS.
The ISIDORe consortium, made of the capacities of European ESFRI infrastructures and coordinated networks, proposes to assemble the largest and most diverse research and service providing instrument to study infectious diseases in Europe, from structural biology to clinical trials. Giving scientists access to the whole extent of our state of the art facilities, cutting edge services, advanced equipment and expertise, in an integrated way and with a common goal, will enable or accelerate the generation of new knowledge and intervention tools to ultimately help control SARS CoV 2 in particular, and epidemic prone pathogens in general, while avoiding fragmentation and duplication among European initiatives.
Such a global and interdisciplinary approach is meant to allow the implementation of user projects that are larger, more ambitious and more impactful than the EU supported transnational activities that the consortium is used to run. Our proposition is ambitious but achievable in a timely fashion due to the relevance and previous experience of the partners that we have gathered and that have complementary fields of expertise, which addresses the need for an interdisciplinary effort.
Leveraging all these existing strengths to develop synergies will create an additional value and enhance Europe capacity for controlling emerging or re emerging and epidemic infectious diseases, starting with the COVID 19 pandemic. Such a global and coordinated approach is consistent with the recommendations of the One Health concept and necessary to make significant contributions to solving complex societal problems like epidemics and pandemics.
Topics
Who is involved
| Organisation | City | Country | Role |
|---|---|---|---|
| European Research Infrastructure on Highly Pathogenic Agents | Bruxelles / Brussel | Belgium | Coordinator |
| Biobanks and Biomolecular Resources Research Infrastructure Consortium (bbmri-Eric) | Graz | Austria | Participant |
| Joanneum Research Forschungsgesellschaft Mbh | Graz | Austria | Participant |
| Medizinische Universitaet Wien | Wien | Austria | Participant |
| Medizinische Universitat Graz | Graz | Austria | Participant |
| Vienna Biocenter Core Facilites GmbH | Wien | Austria | Participant |
| Commonwealth Scientific and Industrial Research Organisation | Acton Act | Australia | Participant |
| Brac University | Dhaka | BD | Participant |
| Avia-Gis NV | Zoersel | Belgium | Participant |
| Jrc -Joint Research Centre- European Commission | Bruxelles / Brussel | Belgium | Participant |
| Katholieke Universiteit Leuven | Leuven | Belgium | Participant |
| Universite De Liege | Liege | Belgium | Participant |
| Vib Vzw | Zwijnaarde - Gent | Belgium | Participant |
| Ministere De La Sante | Ouagadougou | Burkina Faso | Participant |
| Roumen Tsanev Institute of Molecular Biology Bulgarian Academy of Sciences | Sofia | Bulgaria | Participant |
| Eidgenoessisches Departement Des Innern | Bern | Switzerland | Participant |
| Fondazione per L'istituto Di Ricerca in Biomedicina | Bellinzona | Switzerland | Participant |
| Scuola Universitaria Professionale Della Svizzera Italiana | Manno | Switzerland | Participant |
| Swiss Clinical Trial Organisation (scto) | Bern | Switzerland | Participant |
| Universitat Basel | Basel | Switzerland | Participant |
| Universitat Zurich | Zurich | Switzerland | Participant |
| Vaccine Formulation Institute(ch)ltd | Plan Les Ouates | Switzerland | Participant |
| Biotechnologicky Ustav Av Cr Vvi | Vestec | Czechia | Participant |
| Masarykova univerzita | Brno | Czechia | Participant |
| Univerzita Karlova | Praha 1 | Czechia | Participant |
| Univerzita Palackeho V Olomouci | Olomouc | Czechia | Participant |
| Ustav Molekularni Genetiky Av Cr V.v.i. | Praha 4 | Czechia | Participant |
| Bernhard-Nocht-Institut Fuer Tropenmedizin | Hamburg | Germany | Participant |
| Charite - Universitaetsmedizin Berlin | Berlin | Germany | Participant |
| European Infrastructure of Open Screening Platforms for Chemical Biology European Research Infrastucture Consortium (eu-Openscreen Eric) | Berlin | Germany | Participant |
| European Molecular Biology Laboratory | Heidelberg | Germany | Participant |
| European Vaccine Initiative eV | Heidelberg | Germany | Participant |
| Forschungsverbund Berlin eV | Berlin | Germany | Participant |
| Fraunhofer Gesellschaft Zur Forderung Der Angewandten Forschung eV | Munchen | Germany | Participant |
| Friedrich Loeffler Institut - Bundesforschungsinstitut Fuer Tiergesundheit | Greifswald-Insel Riems | Germany | Participant |
| Helmholtz-Zentrum Fur Infektionsforschung GmbH | Braunschweig | Germany | Participant |
| Hits Ggmbh | Heidelberg | Germany | Participant |
| Infrafrontier Eric | Neuherberg | Germany | Participant |
| InSCREENeX GmbH | Braunschweig | Germany | Participant |
| Johann Wolfgang Goethe-Universitaet Frankfurt Am Main | Frankfurt Am Main | Germany | Participant |
| Julius Kuhn-Institut Bundesforschungsinstitut Fur Kulturpflanzen | Quedlinburg | Germany | Participant |
| Kks-Netzwerk eV -Netzwerk Der Koordinierungszentren Fur Klinische Studien | Berlin | Germany | Participant |
| Leibniz-Institut Dsmz-Deutsche Sammlung Von Mikroorganismen Und Zellkulturen GmbH | Braunschweig | Germany | Participant |
| Max-Planck-Gesellschaft Zur Forderung Der Wissenschaften eV | Munchen | Germany | Participant |
| Philipps Universitaet Marburg | Marburg | Germany | Participant |
| Universitaet Leipzig | Leipzig | Germany | Third party |
| Universitatsklinikum Jena | Jena | Germany | Third party |
| Aarhus Universitet | Aarhus C | Denmark | Participant |
| Danmarks Tekniske Universitet | Kongens Lyngby | Denmark | Participant |
| Statens Serum Institut | Kobenhavn S | Denmark | Participant |
| Idryma Iatroviologikon Ereunon Akademias Athinon | Athina | Greece | Participant |
| Idryma Technologias Kai Erevnas | Irakleio | Greece | Participant |
| Agencia Estatal Consejo Superior De Investigaciones Cientificas | Madrid | Spain | Participant |
| Fundacio De Recerca Clinic Barcelona-Institut D Investigacions Biomediques August Pi I Sunyer | Barcelona | Spain | Participant |
| Fundacio Hospital Universitari Vall D'hebron - Institut De Recerca | Barcelona | Spain | Participant |
| Fundacion Centro De Excelencia En Investigacion De Medicamentos Innovadores En Andalucia | Armilla Granada | Spain | Participant |
| Fundacion Para La Investigacion Biomedica Del Hospital Universiatrio La Paz | Madrid | Spain | Participant |
| Institut De Investigacio En Ciencies De La Salut Germans Trias I Pujol | Badalona Barcelona | Spain | Participant |
| Institut De Recerca I Tecnologia Agroalimentaries | Caldes De Montbui Barcelona | Spain | Participant |
| Abo Akademi | Abo | Finland | Participant |
And 99 more organisations. Full list on CORDIS.
Source: CORDIS, European Commission. Data of 5 Nov 2026, reused under the Commission's reuse policy. View on CORDIS · Grant DOI